|
End-of-day quote
Dhaka S.E.
12/11/2026
|
5-day change | 1st Jan Change | ||
| 725.90 BDT | -1.16% |
|
+0.61% | +2.53% |
| Market Cap | 181.56Cr 1.45Cr 1.32Cr 1.22Cr 1.1Cr 2.07Cr 136.94Cr 2.14Cr 15Cr 5.8Cr 73Cr 5.45Cr 5.33Cr 232.2Cr | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 232.19Cr 1.86Cr 1.68Cr 1.56Cr 1.4Cr 2.65Cr 175.13Cr 2.74Cr 19Cr 7.42Cr 94Cr 6.97Cr 6.82Cr 296.95Cr | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | -1.16% | ||
| 1 week | +0.61% | ||
| Current month | -0.66% | ||
| 1 month | -1.21% | ||
| 3 months | -9.58% | ||
| 6 months | -4.02% | ||
| Current year | +2.53% |
| 1 week | 718 | 738 | |
| 1 month | 700.5 | 756.6 | |
| Current year | 689 | 847 | |
| 1 year | 681 | 847 | |
| 3 years | 650 | 1,002.7 | |
| 5 years | 375.3 | 1,302.3 | |
| 10 years | 353 | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.16% | +0.61% | -1.83% | -14.67% | 1.39Cr | ||
| +1.26% | +6.61% | +41.12% | +135.59% | 1,28600Cr | ||
| +0.79% | +3.45% | +46.35% | +93.56% | 69TCr | ||
| +0.20% | +1.28% | +27.01% | +112.80% | 52TCr | ||
| -0.44% | +3.69% | +39.60% | +69.51% | 39TCr | ||
| +0.55% | +0.70% | +59.00% | +44.20% | 36TCr | ||
| -0.12% | +0.74% | +26.78% | +58.43% | 30TCr | ||
| +0.37% | +0.37% | +3.62% | +36.44% | 29TCr | ||
| -0.30% | +1.14% | +38.59% | +74.61% | 25TCr | ||
| +0.08% | +0.71% | +34.25% | +124.32% | 21TCr | ||
| Average | +0.12% | +1.61% | +31.45% | +73.48% | 43TCr | |
| Weighted average by Cap. | +0.54% | +2.79% | +37.63% | +96.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 22Cr 17.54L 15.9L 14.7L 13.27L 25L 17Cr 25.88L 1.77Cr 70.04L 8.84Cr 65.83L 64.44L 28Cr | 23Cr 18.44L 16.71L 15.46L 13.95L 26.28L 17Cr 27.21L 1.86Cr 73.63L 9.29Cr 69.21L 67.74L 29Cr |
| Net income | 96.83L 77.46T 70.2T 64.93T 58.58T 1L 73.04L 1L 8L 3L 39.01L 3L 3L 1.24Cr | 53.09L 42.47T 38.49T 35.6T 32.12T 60.53T 40.05L 62.66T 4L 2L 21.39L 2L 2L 67.9L |
| Net Debt | 44Cr 35.57L 32.23L 29.81L 26.9L 50.69L 34Cr 52.48L 3.58Cr 1.42Cr 18Cr 1.33Cr 1.31Cr 57Cr | 51Cr 40.5L 36.7L 33.95L 30.63L 57.72L 38Cr 59.75L 4.08Cr 1.62Cr 20Cr 1.52Cr 1.49Cr 65Cr |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | BDT 725.90 | -1.16% | 58 |
| 11/26/11 | BDT 734.40 | +1.83% | 28 |
| 10/26/10 | BDT 721.20 | -2.04% | 458 |
| 09/26/09 | BDT 736.20 | +2.42% | 1,076 |
| 08/26/08 | BDT 718.80 | -0.37% | 155 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Select your edition
All financial news and data tailored to specific country editions
















